SCHEMBL13548699

SCHEMBL13548699

COc1ccccc1Oc1ccc2[nH]nc(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)c2c1

nearest known ligand 0.90

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 14/20 0.90
FGFR1 P11362 11/20 0.72
FLT1 P17948 9/20 0.72
BCR P11274 5/20 0.64
KDR P35968 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13548646 0.95 ABL1 (1.00) ABL1FGFR1FLT1BCRKDR
SCHEMBL5866762 0.89 ABL1 (0.87) ABL1FGFR1FLT1BCRKDR
SCHEMBL3537439 0.89 ABL1 (0.85) ABL1FGFR1FLT1BCRKDR
SCHEMBL3537611 0.88 ABL1 (0.84) ABL1FGFR1FLT1BCRKDR
SCHEMBL3531965 0.86 ABL1 (0.84) ABL1FGFR1FLT1BCRKDR
SCHEMBL3538437 0.85 ABL1 (1.00) ABL1FGFR1FLT1BCRKDR
SCHEMBL3533705 0.84 ABL1 (1.00) ABL1FGFR1FLT1BCRKDR
SCHEMBL3538261 0.84 ABL1 (1.00) ABL1FGFR1FLT1BCRKDR
SCHEMBL3534446 0.84 ABL1 (0.72) ABL1FGFR1FLT1BCRKDR
SCHEMBL3538117 0.84 ABL1 (0.75) ABL1FGFR1FLT1BCRKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7642278-B2 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2010-01-05 US disclosed
US-7642278-B2 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2010-01-05 US disclosed